SEHK:1526

Stock Analysis Report

Rici Healthcare Holdings

Executive Summary

Rici Healthcare Holdings Limited, an investment holding company, operates general hospitals, specialty hospitals, medical examination centers, and clinics in the People’s Republic of China.


Snowflake Analysis

Worrying balance sheet with weak fundamentals.


Similar Companies

Share Price & News

How has Rici Healthcare Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1526 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

1.2%

1526

4.4%

HK Healthcare

1.5%

HK Market


1 Year Return

-44.2%

1526

-15.1%

HK Healthcare

5.9%

HK Market

Return vs Industry: 1526 underperformed the Hong Kong Healthcare industry which returned -12.9% over the past year.

Return vs Market: 1526 underperformed the Hong Kong Market which returned 6.4% over the past year.


Shareholder returns

1526IndustryMarket
7 Day1.2%4.4%1.5%
30 Day-4.4%5.2%4.2%
90 Day-8.5%2.7%8.7%
1 Year-44.2%-44.2%-13.2%-15.1%9.8%5.9%
3 Year-55.0%-55.0%-23.4%-28.0%27.7%14.7%
5 Yearn/a-15.9%-23.2%21.4%1.2%

Price Volatility Vs. Market

How volatile is Rici Healthcare Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Rici Healthcare Holdings undervalued compared to its fair value and its price relative to the market?

1.88x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 1526's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 1526's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 1526 is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: 1526 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1526's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 1526 is overvalued based on its PB Ratio (1.9x) compared to the HK Healthcare industry average (1.4x).


Next Steps

Future Growth

How is Rici Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rici Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Rici Healthcare Holdings performed over the past 5 years?

-64.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1526 is currently unprofitable.

Growing Profit Margin: 1526 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 1526 is unprofitable, and losses have increased over the past 5 years at a rate of -64.1% per year.

Accelerating Growth: Unable to compare 1526's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1526 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).


Return on Equity

High ROE: 1526 has a negative Return on Equity (-23.22%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Rici Healthcare Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 1526's short term assets (CN¥954.9M) do not cover its short term liabilities (CN¥1.6B).

Long Term Liabilities: 1526's short term assets (CN¥954.9M) do not cover its long term liabilities (CN¥1.7B).


Debt to Equity History and Analysis

Debt Level: 1526's debt to equity ratio (137.4%) is considered high.

Reducing Debt: 1526's debt to equity ratio has increased from 89.9% to 137.4% over the past 5 years.


Balance Sheet

Inventory Level: 1526 has a high level of physical assets or inventory.

Debt Coverage by Assets: 1526's debt is covered by short term assets (assets are 1.1x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 1526 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 1526 has less than a year of cash runway if free cash flow continues to reduce at historical rates of -58.3% each year


Next Steps

Dividend

What is Rici Healthcare Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.2%markettop25%6.0%industryaverage2.4%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate 1526's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 1526's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1526's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1526's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1526's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

What is the CEO of Rici Healthcare Holdings's salary, the management and board of directors tenure and is there insider trading?

3.1yrs

Average board tenure


CEO

Yixin Fang (54yo)

0.8yrs

Tenure

CN¥3,832,000

Compensation

Dr. Yixin Fang has been Chief Executive Officer of Rici Healthcare Holdings Ltd since March 20, 2019. Dr. Fang serves as the Chairman of Rici Healthcare Holdings Limited and also has been its Executive Dir ...


CEO Compensation Analysis

Compensation vs Market: Yixin's total compensation ($USD556.19K) is above average for companies of similar size in the Hong Kong market ($USD296.12K).

Compensation vs Earnings: Yixin's compensation has been consistent with company performance over the past year.


Board Age and Tenure

3.1yrs

Average Tenure

51yo

Average Age

Experienced Board: 1526's board of directors are considered experienced (3.1 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Management Team

  • Xiaoying Lin (41yo)

    COO, VP

    • Tenure: 0.6yrs
  • Hong Mei (54yo)

    VP & Executive Director

    • Tenure: 5.5yrs
    • Compensation: CN¥4.02m
  • Yixin Fang (54yo)

    Chairman & CEO

    • Tenure: 0.8yrs
    • Compensation: CN¥3.83m
  • Ying Cao

    Deputy General Manager of Medical Examination Business Department

    • Miao Xiaohui

      Chief Medical Officer

      • Li Zhu

        Chief Legal Officer

        • Yan Wang (39yo)

          Chief Financial Officer

          • Tenure: 2.7yrs
        • Haoze Fang (30yo)

          VP, GM of Medical Examination Business Department & Executive Director

          • Tenure: 0.6yrs
        • Kun Chen

          Company Secretary


          Board Members

          • Sze Wing Wong (39yo)

            Independent Non-Executive Director

            • Tenure: 3.6yrs
            • Compensation: CN¥180.00k
          • Pei Jiang (51yo)

            Independent Non-Executive Director

            • Tenure: 2.6yrs
            • Compensation: CN¥150.00k
          • Xiaoying Lin (41yo)

            COO, VP

            • Tenure: 0.6yrs
          • Hong Mei (54yo)

            VP & Executive Director

            • Tenure: 5.5yrs
            • Compensation: CN¥4.02m
          • Yixin Fang (54yo)

            Chairman & CEO

            • Tenure: 0.8yrs
            • Compensation: CN¥3.83m
          • Yan Jiao (41yo)

            Non Executive Director

            • Tenure: 4.9yrs
          • Yong Wang (53yo)

            Independent Non-Executive Director

            • Tenure: 3.6yrs
            • Compensation: CN¥180.00k
          • Qiyong Yao (55yo)

            Non-Executive Director

            • Tenure: 2.6yrs
          • Haoze Fang (30yo)

            VP, GM of Medical Examination Business Department & Executive Director

            • Tenure: 0.6yrs

          Company Information

          Rici Healthcare Holdings Limited's company bio, employee growth, exchange listings and data sources


          Key Information

          • Name: Rici Healthcare Holdings Limited
          • Ticker: 1526
          • Exchange: SEHK
          • Founded: 2000
          • Industry: Health Care Facilities
          • Sector: Healthcare
          • Market Cap: HK$1.368b
          • Shares outstanding: 1.59b
          • Website: https://www.rich-healthcare.com

          Number of Employees


          Location

          • Rici Healthcare Holdings Limited
          • Building 1
          • 20th Floor
          • Shanghai
          • China

          Listings

          TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
          1526SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDOct 2016

          Biography

          Rici Healthcare Holdings Limited, an investment holding company, operates general hospitals, specialty hospitals, medical examination centers, and clinics in the People’s Republic of China. It provides healthcare services in the areas of gynecology, obstetrics, pediatrics, postpartum rehabilitation, and obstetrics. As of December 31, 2018, it had 55 medical examination centers. The company was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China. 


          Company Analysis and Financial Data Status

          All financial data provided by Standard & Poor's Capital IQ.
          DataLast Updated (UTC time)
          Company Analysis2020/01/18 12:51
          End of Day Share Price2020/01/17 00:00
          Earnings2019/06/30
          Annual Earnings2018/12/31


          Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.